Blackstone bets big on life-science buildings with $14.6B deal

Investor interest has intensified as researchers pursue a Covid-19 vaccine

National /
Oct.October 16, 2020 05:15 PM
Blackstone’s Kathleen McCarthy with 440 Saw Mill River Road, Ardsley, New York and 1000 Gateway Boulevard in San Francisco, California (left) (Blackstone; BioMed Realty)

Blackstone’s Kathleen McCarthy with 440 Saw Mill River Road, Ardsley, New York and 1000 Gateway Boulevard in San Francisco, California (left) (Blackstone; BioMed Realty)

Blackstone Group sold a portfolio of 93 life-science buildings to a separate fund the asset manager controls for $14.6 billion, in a transaction that represents a $6.5 billion gain in value from when it acquired the properties in 2016.

The New York-based commercial real estate behemoth said that rather than cash out of the BioMed Realty Trust holdings, which is the second-largest owner of life science buildings in the U.S., it sold it to a subsidiary because investors wanted to stay in, the Wall Street Journal reported.

Blackstone’s profit in the sale is the third-largest it has achieved in any fund it manages. Prior to the transaction, which is the first of its kind Blackstone has carried out, the firm considered taking BioMed public or selling the company.

BioMed’s properties are concentrated in the San Francisco Bay Area, San Diego, Boston, Seattle and New York, as well as Cambridge in the United Kingdom, according to its website. Investment bank Morgan Stanley will also seek bids to determine if a higher offer exists.

The demand for life-science buildings has intensified, especially as new treatments are developed by startups instead of at large pharmaceutical companies. The existing demand for space intensified with the onset of Covid-19, as researchers work to develop a vaccine.

Kathleen McCarthy, Blackstone’s global co-head of real estate, said that the BioMed life sciences portfolio has not suffered the drops in rent collections that have plagued other sectors. The portfolio’s occupancy stands at 97 percent, McCarthy told the Journal, and about half of its tenants are working on Covid-19 testing or vaccines.

Although the sector does face risks of high maintenance costs for labs, and there can be a significant lag time between research and selling treatments to the public, other investors are bullish on life sciences, too.

In San Francisco, Ventas, a publicly-traded healthcare REIT based in Chicago, acquired a life-sciences campus from Bain Capital Real Estate for $1.02 billion. Bain acquired the Genesis South San Francisco campus in 2015.

“Strong and growing capital flows into the life science sector are accelerating innovation and discovery,” said Ventas CEO Debra Cafaro.

[WSJ] — Georgia Kromrei


Related Articles

arrow_forward_ios
Illustration of Stefan Soloviev (HaydenSoloviev, CC BY-SA 4.0, via Wikimedia Commons, Getty)
Soloviev bets long-dormant Midtown East site in casino sweepstakes
Soloviev bets long-dormant Midtown East site in casino sweepstakes
CHIP's Jay Martin and HCR Commissioner RuthAnne Visnauskas (Getty)
Lies, damn lies, and statistics: Did rent-stabilized vacancies really fall?
Lies, damn lies, and statistics: Did rent-stabilized vacancies really fall?
PulteGroup's Ryan R. Marshall and RedFin's Glenn Kelman (PulteGroup, RedFin, Getty)
Wall Street is bidding up housing stocks again
Wall Street is bidding up housing stocks again
Empire Capital Holdings' Josh Rahmani, Hakimian Capital's Michael Hakimian, RXR's Scott Rechler and 1330 6th Avenue (Getty, Hakimian Capital, Empire Capital Holdings, 1330aofa.com)
Empire Capital, partners close on $320M deal for 1330 Sixth Ave
Empire Capital, partners close on $320M deal for 1330 Sixth Ave
Urban Commons' Salvatore G. Takoushian with Wagner at the Battery
Urban Commons puts FiDi hotel into bankruptcy
Urban Commons puts FiDi hotel into bankruptcy
(Illustration by The Real Deal; Getty)
Multifamily faces stricter emission caps
Multifamily faces stricter emission caps
Amir Korangy, Michael Shvo and Jeff Greene
Michael Shvo and Jeff Greene talk distress, opportunities in office
Michael Shvo and Jeff Greene talk distress, opportunities in office
(Getty)
Developers went on permit palooza before 421a expiration
Developers went on permit palooza before 421a expiration
arrow_forward_ios

The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

Loading...